KOID ETF: Your Gateway To The $5 Trillion Humanoid Robotics Market KOID ETF: Your Gateway To The $5 Trillion Humanoid Robotics Market - Tesla ( NASDAQ:TSLA ) , KraneShares Global Humanoid and Embodied Intelligence Index ETF ( NASDAQ:KOID )
KOID ETF targets companies powering humanoid robotics and embodied AI, including sectors like semiconductors. The fund tracks the MerQube Global Humanoid and Embodied Intelligence Index, aiming to tap into a projected $5 trillion market opportunity. Ready to turn the market's comeback into ...
ALL4 Mining: The most trusted high-yield smart cloud mining platform for Bitcoin ( BTC ) and Dogecoin ( DOGE ) in 2025
Speculate on price movements, claim up to $200 in bonuses, and start with risk-free paper trading with crypto futures on Plus500. © 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Why Lululemon Athletica Stock Crashed Today
It's not Lululemon's fault -- really! -- but this stock is probably not a near-term buy.
Dollar General, Disney, and Meta in the Discussion Spotlight
In this podcast, Motley Fool contributors Anand Chokkavelu, Jason Hall, and Matt Frankel discuss:To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. When you're ready to invest, check out this top 10 list of stocks to buy.A full transcript is ...
Phathom Pharmaceuticals Announces Positive FDA Decision to Recognize 10 Years of Regulatory Exclusivity for VOQUEZNA® ( vonoprazan ) Tablets through May 3, 2032
FLORHAM PARK, N.J., June 06, 2025 ( GLOBE NEWSWIRE ) -- Phathom Pharmaceuticals, Inc. ( Nasdaq: PHAT ) today announced that the U.S. Food and Drug Administration ( FDA ) has approved Phathom's Citizen Petition filed on December 11, 2024 and communicated the Agency's intention to correct the ...
ABM Industries' Bookings Hit a Record in Its Fiscal First Half
ABM Industries ( NYSE:ABM ) reported its fiscal 2025 second-quarter results on June 5, 2025, achieving 3.8% organic revenue growth, $2.1 billion in revenue, and adjusted EPS of $0.86. The company, which provides a range of services to commercial properties, including custodial, facilities ...
Phathom Pharmaceuticals Announces Positive FDA Decision to Recognize 10 Years of Regulatory Exclusivity for VOQUEZNA® ( vonoprazan ) Tablets through May 3, 2032 - Phathom Pharmaceuticals ( NASDAQ:PHAT )
FLORHAM PARK, N.J., June 06, 2025 ( GLOBE NEWSWIRE ) -- Phathom Pharmaceuticals, Inc. PHAT today announced that the U.S.
IDEX Biometrics ASA: New date for the share consolidation and ISIN change
Reference is made to the stock exchange notice from IDEX Biometrics ASA ( the "Company" ) on 11 April 2025 regarding key information relating to share consolidation and change of ISIN as resolved by the 11 April 2025 Extraordinary General Meeting in the Company ( the "EGM" ) .
$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today - EQT ( NYSE:EQT )
EQT EQT has outperformed the market over the past 5 years by 14.91% on an annualized basis producing an average annual return of 28.21%. Currently, EQT has a market capitalization of $33.20 billion.